Cigna Corporation's Upcoming Quarterly Earnings: A Financial Overview

Analysts estimate an EPS of $7.14 and revenue of $62.6 billion for the upcoming quarterly earnings. The company's P/E ratio stands at approximately 16.27, with a price-to-sales ratio of about 0.31. Cigna's debt-to-equity ratio is approximately 0.76, indicating its financial leverage and stability.

Cigna Corporation (NYSE:CI), a global health services company, competes with major players in the health insurance industry, such as UnitedHealth Group and Anthem. The company is set to release its quarterly earnings on July 31, 2025, with analysts estimating an EPS of $7.14 and revenue of $62.6 billion.

Wall Street expects Cigna's earnings to show a year-over-year increase, driven by higher revenues. The consensus estimate for the quarterly earnings is $7.14 per share. The stock's movement will depend on whether the actual results exceed or fall short of these expectations. A positive earnings surprise could lead to a rise in Cigna's stock price, while a miss might result in a decline.

Cigna's financial metrics provide insight into its market valuation and financial health. The company's P/E ratio is approximately 16.27, indicating how the market values its earnings. The price-to-sales ratio is about 0.31, suggesting the stock price relative to its revenue. The enterprise value to sales ratio is around 0.39, reflecting the company's total valuation compared to its sales.

The enterprise value to operating cash flow ratio is approximately 13.46, offering insight into Cigna's cash flow efficiency. The earnings yield is about 6.15%, providing a perspective on the return on investment. The debt-to-equity ratio is approximately 0.76, indicating the company's financial leverage. The current ratio is around 0.78, measuring the company's ability to cover short-term liabilities with short-term assets.